# Evidence Strength & Next Steps Summary
**Date:** 2026-03-12
**Status:** Audit Complete. Hypothesis Refinement Required.

## 1. Evidence Baseline Assessment
The audit of the `outputs/afcc/` data (2026-01-09 to 2026-02-16) reveals a critical distinction between **narrative trends** and **measured reality**.

*   **Data Freshness:** The "evolution" of LBX1 structural features is a **fiction**. The underlying metric vectors are bit-for-bit identical across 17 runs. Any perceived trend is due to changes in reporting frequency or metadata schemas (`dise_score`), not protein folding.
*   **Structural Reality:** When weighted by confidence (pLDDT), **LBX1** collapses to a **Tier 3** candidate (Rank 18/25). It lacks the intrinsic stiffness or anisotropy to act as a "Molecular Caliper" or "Counter-Curve" element on its own.
*   **True Mechanosensors:** The analysis **strongly confirms** **PIEZO2**, **CNNM2**, and **FBLN5** as high-confidence, high-anisotropy structures capable of passive mechanical sensing.

## 2. Hypothesis Pivot: The "Modular Integrator" Model
We must abandon the "LBX1 as a Rod" model. The data (Intermediate Anisotropy ~2.27, High Blockiness ~7.35) supports a new model:

**The "Modular Integrator" Hypothesis:**
*   LBX1 is a flexible, multi-domain protein (High PAE Blockiness).
*   It does not *sense* curvature directly via bending (like PIEZO2).
*   Instead, it *integrates* mechanical signals via **differential localization** (Nuclear Shuttling) or **condensation** (Phase Separation), driven by its disordered linkers.

## 3. Top 3 High-Leverage Experiments
To validate this new model, we require functional assays, not more static structure prediction.

1.  **The Nuclear Tether Test (LINC Perturbation):**
    *   *Objective:* Determine if LBX1 nuclear entry depends on physical cytoskeleton-nucleus coupling.
    *   *Critical Readout:* Nuclear/Cytoplasmic ratio in KASH-DN cells under strain.

2.  **The "Blocky" Deletion Series:**
    *   *Objective:* Identify which domain (N-term, C-term, IDR) confers mechanosensitivity.
    *   *Critical Readout:* Loss of stretch-response in IDR-deletion mutants.

3.  **In Vitro Condensation (Phase Separation):**
    *   *Objective:* Test if LBX1 forms condensates under crowding pressure (biophysical sensor).
    *   *Critical Readout:* Droplet formation at physiological concentrations ($<10 \mu M$).

## 4. Go/No-Go Recommendation
*   **STOP** all "LBX1 Stiff Rod" narrative development immediately.
*   **GO** on **PIEZO2/ADGRG6** as the primary "Structural Countercurvature" examples.
*   **GO** on **CNNM2** and **FBLN5** as new, high-priority candidates for structural validation.
*   **RECLASSIFY** LBX1 as a "Downstream Responder" pending the results of Experiment 1.

**Final Verdict:** The "Biological Countercurvature" hypothesis stands, but the cast of characters has changed. **PIEZO2 is the rod; LBX1 is the reader.**
